Posted By Mike Rosenthal on March 19, 2010 | Leave a Comment
Israel is making waves in the international drug market. Teva, popularly known as a shoe company but also Israel’s biggest generic drugmaker and the world’s generic market leader, is acquiring the German firm Ratiopharm, thereby acquiring the world’s second largest in the industry. The merger will give Teva an estimated $2.5 billion boost in sales annually. Teva even beat out well known US firms like Pfizer in chasing the deal.
Read More
